Natus Medical Incorporated (BABY) Holdings Boosted by Strs Ohio
Strs Ohio boosted its holdings in shares of Natus Medical Incorporated (NASDAQ:BABY) by 4.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 110,000 shares of the medical equipment provider’s stock after purchasing an additional 5,000 shares during the quarter. Strs Ohio owned approximately 0.34% of Natus Medical worth $4,125,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Karp Capital Management Corp acquired a new position in shares of Natus Medical during the first quarter valued at approximately $242,000. Parametric Portfolio Associates LLC raised its holdings in shares of Natus Medical by 11.3% during the first quarter. Parametric Portfolio Associates LLC now owns 61,434 shares of the medical equipment provider’s stock valued at $2,411,000 after acquiring an additional 6,214 shares during the last quarter. Victory Capital Management Inc. raised its holdings in shares of Natus Medical by 94.0% during the first quarter. Victory Capital Management Inc. now owns 3,184 shares of the medical equipment provider’s stock valued at $125,000 after acquiring an additional 1,543 shares during the last quarter. Municipal Employees Retirement System of Michigan raised its holdings in shares of Natus Medical by 1.5% during the first quarter. Municipal Employees Retirement System of Michigan now owns 7,520 shares of the medical equipment provider’s stock valued at $295,000 after acquiring an additional 110 shares during the last quarter. Finally, OppenheimerFunds Inc. raised its holdings in shares of Natus Medical by 26.7% during the first quarter. OppenheimerFunds Inc. now owns 8,026 shares of the medical equipment provider’s stock valued at $315,000 after acquiring an additional 1,689 shares during the last quarter. 94.44% of the stock is owned by institutional investors and hedge funds.
Natus Medical Incorporated (BABY) opened at 41.90 on Tuesday. Natus Medical Incorporated has a one year low of $31.65 and a one year high of $43.85. The firm’s 50 day moving average price is $38.21 and its 200-day moving average price is $36.17. The firm has a market cap of $1.36 billion, a PE ratio of 72.62 and a beta of 0.95.
Natus Medical (NASDAQ:BABY) last announced its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $0.40 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.02. The business had revenue of $122.60 million for the quarter, compared to analyst estimates of $122.41 million. Natus Medical had a positive return on equity of 12.06% and a negative net margin of 0.62%. The company’s quarterly revenue was up 34.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.39 EPS. Equities analysts predict that Natus Medical Incorporated will post $1.72 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This article was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://theolympiareport.com/2017/10/31/natus-medical-incorporated-baby-holdings-boosted-by-strs-ohio.html.
In other news, Director Robert A. Gunst sold 4,400 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $35.17, for a total transaction of $154,748.00. Following the sale, the director now owns 50,850 shares of the company’s stock, valued at approximately $1,788,394.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William M. Moore sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, August 14th. The stock was sold at an average price of $34.10, for a total value of $102,300.00. Following the sale, the director now directly owns 30,410 shares in the company, valued at approximately $1,036,981. The disclosure for this sale can be found here. 5.50% of the stock is owned by insiders.
BABY has been the subject of a number of research analyst reports. Zacks Investment Research cut Natus Medical from a “hold” rating to a “sell” rating in a report on Friday, July 28th. BidaskClub cut Natus Medical from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $46.50.
Natus Medical Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.